We are live on ! Find out more
PVMCV

Polaris Venture Management Co V Portfolio holdings

AUM $14.1M
1-Year Est. Return 121.41%
This Fund
S&P 500
This Quarter Est. Return
+13.34%
1 Year Est. Return
+121.41%
3 Year Est. Return
+281.18%
5 Year Est. Return
+1,023.01%
10 Year Est. Return
–
AUM
$14.1M
AUM Growth
-$48.3M
Cap. Flow
-$49.5M
Cap. Flow %
-351.04%
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
–
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
FATE icon
Fate Therapeutics
FATE
+$49.5M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LYRA
1
DELISTED
LYRA THERAPEUTICS INC
LYRA
$10M 71.28%
22,017
– –
XFOR icon
2
X4 Pharmaceuticals
XFOR
$348M
$1.65M 11.7%
10,383
– –
ATYR
3
aTyr Pharma
ATYR
$47.6M
$1.19M 8.42%
130,572
– –
DARE icon
4
Dare Bioscience
DARE
$18.7M
$545K 3.87%
27,187
– –
GNCA
5
DELISTED
Genocea Biosciences, Inc.
GNCA
$379K 2.69%
197,345
– –
PULM icon
6
Pulmatrix
PULM
$6.21M
$288K 2.04%
17,972
– –
FATE icon
7
Fate Therapeutics
FATE
$330M
– –
-569,889
Closed -$49.5M

Similar funds

IFC
Intact Financial Corporation Toronto, Ontario, Canada $14M AUM
AG
Ashmore Group London, United Kingdom $16.3M AUM 57.83% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
IR
Invictus RG Hamilton, Bermuda $8.9M AUM 56.32% 1-Year Est. Return
CCM
Copernicus Capital Management San Francisco, California $8.26M AUM 37.91% 1-Year Est. Return
EIP
Edgbaston Investment Partners $20.3M AUM 35.98% 1-Year Est. Return
AAM
Areion Asset Management Hong Kong $7.82M AUM 16% 1-Year Est. Return
OEP
Ocean Endowment Partners Chicago, Illinois $20.6M AUM 27.63% 1-Year Est. Return

Polaris Venture Management Co V's Q3 2021 Portfolio in Review

As of Q3 2021, Polaris Venture Management Co V held 7 positions worth $14.1M, down 77% from $62.4M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Polaris Venture Management Co V withdrew a net $49.5M in Q3 2021, closing 1 position. Its most notable exit was Fate Therapeutics, an estimated $49.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Polaris Venture Management Co V fully exited Fate Therapeutics in Q3 2021, selling an estimated $49.5M.
  • Polaris Venture Management Co V's ten largest holdings make up 100% of its $14.1M portfolio in Q3 2021.
  • Polaris Venture Management Co V opened 0 new positions and closed 1 in Q3 2021.
  • Polaris Venture Management Co V's portfolio value fell 77% quarter-over-quarter to $14.1M.

Based on Polaris Venture Management Co V's 13F filing for Q3 2021, filed 12 Nov 2021.